Abstract:Abstract Background Squamous cell carcinoma of the head and neck (SCCHN) is one of the most common types of cancer that cause a substantial number of cancer-related deaths. Our previous study has revealed that makorin ring finger protein 3 (MKRN3) may act as a key regulator of the SCCHN tumorigenesis; however, its specific role in SCCHN progression has not been reported. Methods The Cancer Genome Atlas (TCGA) data analysis and quantitative polymerase chain reaction (qPCR) were used to quantify the MKRN3 mRNA expression levels in SCCHN; immunohistochemical staining or immunoblotting analyses were performed to detect MKRN3 protein expression. Kaplan–Meier plotter was used to assess the prognostic values of MKRN3 in terms of overall survival and disease-free survival. The expression differences based on various clinicopathological features were evaluated using subgroup analysis and forest map analysis. The regulatory mechanism of MKRN3 was further investigated using gene ontology and Kyoto Encyclopedia of Genes and Genomes analyses. Subsequently, STRING was used to perform a co-expression and enrichment analysis for MKRN3. Homologous modeling, molecular docking, and western blot analyses were performed to investigate the relationship between MKRN3 and its potential target gene P53. Results MKRN3 was ectopically expressed between cancerous and noncancerous SCCHN tissues, and its expression level was tightly associated with high T classifications as well as advanced clinical stages. qPCR analysis revealed that MKRN3 was upregulated in the SCCHN cell line. Moreover, Kaplan–Meier and Cox regression analyses indicated that SCCHN patients with high MKRN3 expression had poorer prognosis and that MKRN3 was a potential prognostic marker for SCCHN. Using gene ontology and Kyoto Encyclopedia of Genes and Genomes analyses, we determined that MKRN3 may be involved in the regulation of synthesis and metabolism and cell growth, death and motility, as well as cancer pathways associated with SCCHN progression. Mechanism investigation further revealed that P53, a potential target of MKRN3, may be involved in the SCCHN tumorigenesis mediated by MKRN3. Conclusions We performed a comprehensive evaluation of the clinical significance of MKRN3 and explored its underlying mechanisms. We concluded that MKRN3 represents a valuable predictive biomarker and potential therapeutic target in SCCHN.

E3 Ligase MKRN3 is a Tumor Suppressor Regulating PABPC1 Ubiquitination in Non–small Cell Lung Cancer

MKRN3-mediated ubiquitination of Poly(A)-binding proteins modulates the stability and translation of GNRH1 mRNA in mammalian puberty

The rs6576457 G > A variant in the MKRN3 gene promoter significantly increases the risk of central precocious puberty and lung cancer in Hubei Chinese population

Interplay Of Mkp-1 And Nrf2 Drives Tumor Growth And Drug Resistance In Non-Small Cell Lung Cancer

MKRN3 regulates the epigenetic switch of mammalian puberty via ubiquitination of MBD3

NPM3 As a Novel Oncogenic Factor and Poor Prognostic Marker Contributes to Cell Proliferation and Migration in Lung Adenocarcinoma

Elevated expression of MKRN3 in squamous cell carcinoma of the head and neck and its clinical significance

A Novel Loss-of-Function MKRN3 Variant in a Chinese Patient with Familial Precocious Puberty: A Case Report and Functional Study.

MUC3A Promotes Non-Small Cell Lung Cancer Progress Via Activating NFκB Pathway and Attenuates Radiosensitivity

Identification of Microrna-615-3p As a Novel Tumor Suppressor in Non-Small Cell Lung Cancer.

The Functional Study of a Novel MKRN3 Missense Mutation Associated with Familial Central Precocious Puberty.

Abstract 4167: MUC3A Promotes Lung Cancer Progress Via Activating NFκB Pathway and Attenuates Radiosensitivity

Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer

MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer

GPRC5A Deficiency Leads to Dysregulated MDM2 Via Activated EGFR Signaling for Lung Tumor Development

CRL2KLHDC3 mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression

Long Non-coding RNA EBLN3P Regulates UHMK1 Expression by Sponging miR-323a-3p and Promotes Colorectal Cancer Progression

MiR-326/Sp1/KLF3: A Novel Regulatory Axis in Lung Cancer Progression

MAPK Kinase 3 is a Tumor Suppressor with Reduced Copy Number in Breast Cancer

MLL3 Suppresses Tumorigenesis Through Regulating TNS3 Enhancer Activity

MKRN3 Interacts With Several Proteins Implicated in Puberty Timing but Does Not Influence GNRH1 Expression